UCB Cimzia BLA Submission Could Provide First Subcutaneous Injection For Crohn’s
This article was originally published in The Pink Sheet Daily
Executive Summary
Requested priority review could result in approval by early September for competitor to J&J’s Remicade and AstraZeneca’s Entocort EC.